Tiragolumab, CAS 1918185-84-8

Description: Tiragolumab(MTIG-7192A) is a monoclonal antibody that targets T-cell immunoglobulin and the ITIM structural domain (TIGIT).Tiragolumab is often used in combination with the PD-L1 inhibitor, Atezolizumab, for the treatment of solid malignant tumors such as non-small cell lung cancer.

CAS Number: 1918185-84-8

References: Houssaini MS, et al. Advances in the management of non-small cell lung cancer (NSCLC): A new practice changing data from asco 2020 annual meeting. Cancer Treat Res Commun. 2020;25:100239.

• SKU: TGMT35392-50mg
• Manufacturer: TargetMol Chemicals
• Manufacturer SKU: T35392-50mg
• Package Unit: 50 mg
• Quantity Unit: STK